Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-25 @ 4:50 AM
NCT ID:
NCT00276718
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven malignant germ cell tumors at all stages
* Testicular tumors
* Stage I - Confined to testes
* Stage II - Confined to testes and retroperitoneal/abdominal lymph nodes
* Stage III - Supradiaphragmatic nodal disease (mediastinal and/or supraclavicular)
* Stage IV - Extralymphatic spread (liver, lung, bone, brain, skin, etc.)
* Ovarian, uterine, vaginal, and sacrococcygeal tumors
* Stage I - Confined to ovary/uterus/vagina/pre- and postsacral area
* Stage II - Spread limited to the pelvis
* Stage III - Spread limited to the abdomen (excluding liver)
* Stage IV - Spread to liver or beyond the abdominal cavity
* Abdominal, retroperitoneal, and thoracic primary tumors
* Stage I - Confined to site of origin and resectable
* Stage II - Local spread
* Stage III - Extensive spread confined to one side of the diaphragm (excluding the liver)
* Stage IV - Tumor spread to the liver, to both sides of the diaphragm, and/or to bones, bone marrow, brain, etc.
* Intracranial germ cell tumor cases allowed even if an alternative protocol is being followed
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
15 Years
Study:
NCT00276718
Study Brief:
Protocol Section:
NCT00276718